The SAHPRA blood-pressure medicine warning concerns a rare but potentially life-threatening swelling reaction linked to several medicines used for hypertension and heart conditions. Importantly for ordinary South Africans, the affected class includes enalapril, a medicine commonly supplied through government clinics.
This does not mean that enalapril or every blood-pressure tablet is unsafe. ACE inhibitors remain valuable treatments, and most people taking them will never experience this reaction. The warning is intended to help patients recognise the symptoms early, seek emergency assistance and avoid being given the same type of medicine again after a confirmed reaction.
Public-sector patients also have alternative treatments. Access may not always be as broad or convenient as it is in private healthcare, but patients should not assume that they have no options.
Table of Contents
1. What is SAHPRA warning patients about?
On 20 August 2026, the South African Health Products Regulatory Authority issued a safety warning about ACE inhibitor-induced angioedema.
Angioedema is sudden swelling beneath the skin or in deeper tissues. When it affects the tongue, throat or voice box, it can block the airway and become life-threatening.
ACE inhibitors lower blood pressure by affecting a system that controls the tightening and relaxation of blood vessels. They can also increase the level of a substance called bradykinin. In a small number of susceptible patients, this may contribute to dangerous swelling.
One of the most important points in the SAHPRA blood-pressure medicine warning is that the reaction can happen at any stage of treatment. It may develop:
- Soon after the first few doses
- Several weeks after starting treatment
- After months or years of apparently trouble-free use
A patient should therefore not dismiss sudden swelling simply because they have taken the same medication safely for a long time.
According to the official SAHPRA safety warning, ACE inhibitor treatment must be stopped and should never be reintroduced after a patient experiences confirmed ACE-inhibitor-induced angioedema.
2. Which blood-pressure medicines are affected?
The warning applies to a group of medicines known as angiotensin-converting enzyme inhibitors, or ACE inhibitors. It does not apply to every medicine used to treat high blood pressure.
SAHPRA specifically named seven active ingredients:
- Captopril
- Enalapril
- Lisinopril
- Perindopril
- Quinapril
- Ramipril
- Trandolapril
Patients can usually find the active ingredient on the clinic label, medicine packet or dispensing record. Brand names may differ, so checking only the brand can be confusing.
If you cannot identify your medicine, take the packet or clinic card to a pharmacist, nurse or doctor and ask whether it contains an ACE inhibitor.
These medicines are not used only for high blood pressure. Doctors may also prescribe them for:
- Heart failure
- Reduced heart function
- Certain kidney conditions
- Protection of the heart or kidneys in selected patients
This is one reason patients should not stop taking an ACE inhibitor without a safe replacement plan.
Medicines such as amlodipine, hydrochlorothiazide, indapamide and losartan are not ACE inhibitors, although they have their own possible side effects and precautions.
3. Is this warning relevant to government clinics?
Yes. The SAHPRA warning is relevant to public healthcare users because enalapril is used in South Africa’s public healthcare system and may be prescribed at government clinics and hospitals.
Public facilities follow the National Department of Health’s Standard Treatment Guidelines and Essential Medicines List. These guidelines help healthcare professionals select medicines that are considered effective, safe and affordable within the public system.
The current national guidance is contained in the 2024 Primary Healthcare Standard Treatment Guidelines and Essential Medicines List.
The medicine offered to an individual patient may depend on:
- The person’s blood-pressure readings
- Their age
- Pregnancy or plans to become pregnant
- Kidney function
- Diabetes or heart disease
- Previous medicine reactions
- Other medication being taken
- Provincial procurement and local stock availability
Not every government clinic will necessarily stock all seven ACE inhibitors named by SAHPRA. Enalapril is likely to be the name most familiar to many public-sector patients.
Public patients should receive counselling about important side effects. However, busy clinics and short consultations may mean that the risk is not always explained in enough detail. Patients who have collected the same treatment for years may also assume that a new reaction cannot be caused by a familiar medicine.
SAHPRA’s message is that delayed reactions are possible and that sudden swelling must always be taken seriously.
4. Which alternatives are available—and do they work?
Yes, other medicines can lower blood pressure effectively. An alternative is not automatically weaker or inferior. The correct replacement depends on why the ACE inhibitor was prescribed and the patient’s wider medical condition.
Amlodipine
Amlodipine is widely used to treat high blood pressure and works by relaxing blood vessels through a different mechanism from ACE inhibitors.
It can effectively control hypertension, but it may cause gradual swelling around the ankles. This is different from the sudden swelling of the lips, tongue or throat associated with angioedema.
Diuretics
Hydrochlorothiazide and indapamide help the body remove excess salt and water. They can be effective alone or in combination with another blood-pressure medicine.
Depending on the patient, healthcare professionals may need to monitor kidney function and electrolyte levels.
Angiotensin receptor blockers
An angiotensin receptor blocker, or ARB, such as losartan may be considered for certain patients who cannot tolerate an ACE inhibitor.
ARBs work on a related blood-pressure pathway but do not affect bradykinin in exactly the same way. This generally makes angioedema less likely than it is with ACE inhibitors. However, the risk may not be zero, especially in someone with a previous reaction. A clinician must evaluate whether an ARB is suitable.
5. Are alternatives available only in private healthcare?
No. Public-sector patients have treatment alternatives, including commonly used medicines such as amlodipine and selected diuretics. Losartan may also be available when a patient meets the relevant clinical criteria.
However, private patients may have access to a wider selection of brands, fixed-dose combinations or newer medicines. Public-sector choices can be influenced by the Essential Medicines List, facility level, referral requirements and stock availability.
If a suitable alternative is unavailable at a small clinic, the patient may require assessment or referral. A serious adverse reaction should not simply be dismissed because someone cannot afford to purchase medication privately.
6. Warning signs patients and families must recognise
Sudden swelling of the tongue, mouth, lips or throat—particularly with difficulty breathing, swallowing or speaking—requires immediate medical attention.
Let’s break it down. ACE-inhibitor angioedema may involve the:
- Lips
- Tongue
- Mouth
- Face
- Throat or voice box
- Hands, feet or other extremities
The most dangerous warning signs include:
- Difficulty breathing
- Trouble swallowing
- A tight or closing sensation in the throat
- A suddenly enlarged tongue
- A changed, muffled or hoarse voice
- Drooling or difficulty managing saliva
- Rapidly worsening swelling around the mouth or face
The reaction may occur without itching, hives or a visible rash. This can make it look different from an ordinary allergic reaction.
Patients should also understand that not every type of swelling means the same thing. Gradual ankle swelling can occur with amlodipine and may not be an airway emergency. However, it should still be reported to the clinic because the dose or treatment plan may need to be reviewed.
Sudden tongue, mouth or throat swelling is entirely different and should be treated as an emergency.
7. What should someone do if swelling develops?
If the lips, tongue, mouth or throat begin to swell—especially when breathing, swallowing or speaking is affected—take the following steps:
- Treat it as a medical emergency. Do not wait at home to see whether it improves.
- Go to the nearest emergency department or call emergency services. In South Africa, 112 can be called from a cellphone.
- Take your medicine packet or clinic card with you. This helps emergency staff identify the medicine quickly.
- Tell healthcare workers that you take an ACE inhibitor. Explain when the swelling began and when you took your last dose.
- Do not take another dose until you have been urgently assessed. A clinician must decide whether the medicine caused the reaction.
- Ensure that the reaction is recorded. The medicine name and reaction should be clearly entered in your clinic file and other medical records.
- Tell future healthcare providers. Inform every doctor, nurse, pharmacist and dentist about the previous reaction.
Patients should not rely on an antihistamine or home remedy. SAHPRA explains that bradykinin-related angioedema may not respond to standard treatments used for ordinary allergic reactions. Emergency healthcare workers may need to focus on protecting the airway.
People who do not have swelling should continue taking their prescribed treatment until they have spoken to a healthcare professional. Uncontrolled hypertension can lead to stroke, heart failure, kidney damage and other serious complications.
8. What are health authorities doing about the risk?
SAHPRA’s response currently focuses on professional awareness, patient education, prevention of repeat exposure and improved reporting.
Healthcare professionals have been reminded to:
- Explain the symptoms to patients receiving ACE inhibitors
- Stop the treatment if ACE-inhibitor-induced angioedema occurs
- Never reintroduce an ACE inhibitor after a confirmed reaction
- Record the reaction clearly in the patient’s medical history
- Communicate the history when a patient moves between facilities
- Prescribe an appropriate alternative where necessary
- Report suspected reactions to SAHPRA
Patients and healthcare workers can report suspected adverse reactions through the Med Safety App, SAHPRA’s electronic reporting system or an adverse-reaction form submitted to adr@sahpra.org.za.
Reporting is important even if the connection between the medicine and reaction has not been fully confirmed. A larger collection of reports helps regulators identify safety patterns and decide whether stronger warnings, label changes or other regulatory action may be needed.
SAHPRA says it will update the public if new scientific information changes the current recommendations.
At present, the August alert does not announce a separate national compensation programme or a special medicine-replacement campaign. Public-sector alternatives are managed through the existing Essential Medicines List, clinical guidelines and referral system.
9. Final thoughts
Government-clinic patients are directly affected by this safety warning because enalapril is used within public healthcare. But the announcement should create awareness rather than panic.
Effective alternative treatments are available in both public and private healthcare. The public system may offer fewer choices, and stock shortages or referral requirements can be frustrating. Nevertheless, a patient who has experienced a serious reaction should not be expected to remain untreated or purchase unaffordable private medication without assistance.
The most important message is simple: continue your prescribed blood-pressure treatment if you are well, but seek emergency care immediately if your lips, tongue, mouth or throat begin to swell.
10. Frequently Asked Questions
1. Which blood-pressure medicines are included in the SAHPRA warning?
The warning applies to ACE inhibitors, including captopril, enalapril, lisinopril, perindopril, quinapril, ramipril and trandolapril. It does not apply to every type of blood-pressure medicine.
2. Is enalapril available at South African government clinics?
Yes. Enalapril is used in South Africa’s public healthcare system and may be supplied by government clinics and hospitals. Availability can vary according to local stock, provincial procurement and the patient’s medical needs.
3. Should patients stop taking enalapril because of the warning?
No. Patients who are well should not stop prescribed blood-pressure medicine without professional advice. Uncontrolled hypertension can cause stroke, heart failure and kidney damage. Speak to a healthcare professional if you are concerned.
4. What should I do if my lips, tongue or throat begin to swell?
Seek emergency medical assistance immediately, especially if you have difficulty breathing, swallowing or speaking. Call 112 from a cellphone or go to the nearest emergency department. Take your medicine packet or clinic card with you.
5. Are alternative blood-pressure medicines available at government clinics?
Yes. Depending on the patient’s condition, public facilities may provide alternatives such as amlodipine, hydrochlorothiazide, indapamide or losartan. A healthcare professional must choose the replacement because these medicines are not suitable for every patient or medical condition.
Leave a Reply